Pediatric COVID-19: clinical characteristics and prognostic outcomes

Jing Chen1, Caijin Yan2, Yuling Pan3

  • 1Department of Reproductive Medicine, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, People Republic of China.

Microbiology Spectrum
|August 22, 2025
PubMed

Insights

Pediatric coronavirus disease 2019 (COVID-19) infections are generally mild, but infants under one year old may experience severe respiratory symptoms. Male children show higher susceptibility to COVID-19 infection across all pediatric age groups.

Area of Science:

  • Pediatric infectious diseases
  • Epidemiology
  • Public health

Background:

  • Limited data exists on coronavirus disease 2019 (COVID-19) in infants.
  • Previous studies indicate less than 1% of COVID-19 cases occur in children under 10.
  • Hospitalized pediatric COVID-19 cases require further analysis to understand disease impact.

Purpose of the Study:

  • To analyze the clinical characteristics of pediatric COVID-19.
  • To provide direction for clinical treatment and nursing of pediatric COVID-19.
  • To understand COVID-19's influence on children for better public health responses.

Main Methods:

  • Retrospective analysis of pediatric patients under 18 admitted with COVID-19.
  • Data extraction included demographics, symptoms, clinical progression, and outcomes.
  • Study period: April 2020 to January 2023.

Main Results:

  • 237 pediatric COVID-19 cases were analyzed; all discharged without mortality.
  • Infants under 1 year old (17.72%) had significantly higher rates of respiratory symptoms (88.09%).
  • Male predominance observed (63.29%); higher proportion of asymptomatic cases in children over 10.

Conclusions:

  • Pediatric COVID-19 infections are typically mild, but infants require close monitoring for respiratory distress.
  • Male children exhibit increased susceptibility to COVID-19.
  • Findings have implications for clinical management and public health strategies.

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
517
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
435
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
549
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
44
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.6K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
360